Results 161 to 170 of about 131,495 (304)

Access to out-of-hospital emergency care in Africa: Consensus conference recommendations

, 2016
Christopher Stein, Nee‐Kofi Mould‐Millman, Shaheem de Vries, Lee Wallis   +3 more
openalex   +1 more source

Advancing science and adhering to ethics—Mission and practice of CALAS

Animal Models and Experimental Medicine, EarlyView.
Chinese Association for Laboratory Animal Sciences
wiley   +1 more source

Autoantibody Response Toward Chromatin in Patients With Juvenile Idiopathic Arthritis

Arthritis &Rheumatology, EarlyView.
Objective Patients with juvenile idiopathic arthritis (JIA) frequently exhibit antinuclear antibodies (ANAs), but the specific antigen target recognized by them and the presence of additional autoantibody specificities in patients with JIA remains elusive.
Viola Pitkänen, Terhi Remes‐Pakarinen, Paula Vähäsalo, Milja Möttönen, Minna‐Maija Grönlund, Miika Arvonen, Mikael Knip, Riitta Veijola, Jorma Toppari, Jorma Ilonen, Johanna Lempainen, Anna‐Mari Schroderus, Liisa Kröger, Tuure Kinnunen   +13 more
wiley   +1 more source

Sjögren Disease—B Cells at the Brink: From Autoimmunity to Lymphomagenesis and the Rise of Novel B Cell–Targeted Therapies

Arthritis &Rheumatology, EarlyView.
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley   +1 more source

Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). [PDF]

Virchows Arch, 2023
Elfgen C, Leo C, Kubik-Huch RA, Muenst S, Schmidt N, Quinn C, McNally S, van Diest PJ, Mann RM, Bago-Horvath Z, Bernathova M, Regitnig P, Fuchsjäger M, Schwegler-Guggemos D, Maranta M, Zehbe S, Tausch C, Güth U, Fallenberg EM, Schrading S, Kothari A, Sonnenschein M, Kampmann G, Kulka J, Tille JC, Körner M, Decker T, Lax SF, Daniaux M, Bjelic-Radisic V, Kacerovsky-Strobl S, Condorelli R, Gnant M, Varga Z.   +33 more
europepmc   +1 more source

Interleukin‐18 levels are associated with disease course in patients with Still's disease treated with IL‐1 inhibitors

Arthritis &Rheumatology, Accepted Article.
Objective To evaluate the prognostic utility of circulating Interleukin‐18 (IL‐18) levels in predicting disease activity, macrophage activation syndrome (MAS), and disease course in Still's disease (SD) patients receiving first‐line IL‐1 inhibitors (IL‐1i).
Matteo Trevisan, Manuela Pardeo, Ivan Caiello, Claudia Bracaglia, Arianna de Matteis, Valentina Matteo, Elena Loricchio, Fabrizio De Benedetti, Giusi Prencipe   +8 more
wiley   +1 more source

'Consensus Conference' zu Pflanzenbiotechnologie in Großbritannien

Technikfolgenabschätzung – Theorie und Praxis, 1995
I. von Berg
doaj   +1 more source

Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping. [PDF]

Brain Sci
Mucci A, Leucht S, Giordano GM, Giuliani L, Wehr S, Weigel L, Galderisi S.   +6 more
europepmc   +1 more source

A management algorithm for patients with intracranial pressure monitoring: the Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC) [PDF]

, 2019
Gregory W. J. Hawryluk, Sergio Aguilera, András Büki, Eileen M. Bulger, Giuseppe Citerio, D. James Cooper, Ramon Diaz Arrastia, Michael N. Diringer, Anthony Figaji, Guoyi Gao, Romergryko G. Geocadin, Jamshid Ghajar, Odette A. Harris, Alan Hoffer, Peter J. Hutchinson, Mathew Joseph, Ryan S. Kitagawa, Geoffrey T. Manley, Stephan A. Mayer, David Menon, Geert Meyfroidt, Daniel B. Michael, Mauro Oddo, David O. Okonkwo, Mayur B. Patel, Claudia S. Robertson, Jeffrey V. Rosenfeld, Andrés M. Rubiano, Juan Sahuquillo, Franco Servadei, Lori Shutter, Deborah M. Stein, Nino Stocchetti, Fabio Silvio Taccone, Shelly D. Timmons, Eve C. Tsai, Jamie S. Ullman, Paul Vespa, Walter Videtta, David W. Wright, Christopher Zammit, Randall M. Chesnut   +41 more
openalex   +1 more source

Long‐Term Outcomes of Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation for Systemic Sclerosis Patients with Impaired Cardiac Function

Arthritis &Rheumatology, Accepted Article.
Objective High intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced SSc. The role of reduced intensity conditioning (RIC) prior to AHSCT in this population remains unclear. We conducted this study to determine the long‐term outcomes of RIC AHSCT in SSc patients with cardiac ...
Yonatan Lean, Carrie Richardson, Anthony Esposito, Katy Bedjeti, George E. Georges   +4 more
wiley   +1 more source